Results 11 to 20 of about 1,435,723 (230)

Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring. [PDF]

PLoS ONE, 2022
Given challenges with adherence to existing HIV prevention products, the development of an extended duration vaginal ring could improve adherence while reducing patient and provider burden.
Marie C D Stoner, Erica N Browne, Holly M Gundacker, Imogen Hawley, Beatrice A Chen, Craig Hoesley, Rachel Scheckter, Jeanna Piper, Devika Singh, Mei Song, Albert Liu, Ariane van der Straten   +11 more
doaj   +3 more sources

Adolescent Girls and Young Women's Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use: a Multi-Country Qualitative Analysis. [PDF]

AIDS Behav, 2023
Effective use of oral pre-exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in Eastern and Southern Africa, partly due to stigma and opposition from key influencers.
Young AM, Mancuso N, Atujuna M, Tenza S, Chitukuta M, Kemigisha D, Ngure K, van der Straten A, Garcia M, Szydlo D, Soto-Torres L, Roberts ST.   +11 more
europepmc   +2 more sources

Vaginal rings for delivery of HIV microbicides

International Journal of Women's Health, 2012
R Karl Malcolm, Susan M Fetherston, Clare F McCoy, Peter Boyd, Ian MajorSchool of Pharmacy, Queen's University Belfast, Belfast, UKAbstract: Following the successful development of long-acting steroid-releasing vaginal ring devices for the ...
McCoy CF, Fetherston SM, Malcolm RK, Boyd P, Major I   +4 more
doaj   +6 more sources

Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world. [PDF]

Contraception, 2022
Ridgeway K, Montgomery ET, Smith K, Torjesen K, van der Straten A, Achilles SL, Griffin JB.   +6 more
europepmc   +2 more sources

Acceptability and Use of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) During Breastfeeding in South Africa, Malawi, Zimbabwe, and Uganda. [PDF]

AIDS Behav, 2023
Stoner MCD, Hawley I, Mathebula F, Horne E, Etima J, Kemigisha D, Mutero P, Dandadzi A, Seyama L, Fabiano Z, Scheckter R, Noguchi L, Owor M, Balkus JE, Montgomery ET.   +14 more
europepmc   +2 more sources

Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial. [PDF]

Lancet HIV, 2023
Nair G, Celum C, Szydlo D, Brown ER, Akello CA, Nakalega R, Macdonald P, Milan G, Palanee-Phillips T, Reddy K, Tahuringana E, Muhlanga F, Nakabiito C, Bekker LG, Siziba B, Hillier SL, Baeten JM, Garcia M, Johnson S, McClure T, Levy L, Livant E, Jacobson C, Soto-Torres L, van der Straten A, Hosek S, Rooney JF, Steytler J, Bunge K, Parikh U, Hendrix C, Anderson P, Ngure K, REACH Protocol Team.   +33 more
europepmc   +2 more sources

Acceptability of the Dapivirine Vaginal Ring in Postmenopausal US Women. [PDF]

AIDS Patient Care STDS, 2022
For women in the United States who remain sexually active beyond child-bearing years, susceptibility to HIV infection remains, yet condom use is low.
Shapley-Quinn MK, Laborde N, Luecke E, Hoesley C, Salata RA, Johnson S, Nel A, Soto-Torres L, Chen BA, van der Straten A.   +9 more
europepmc   +2 more sources

Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal Ring. [PDF]

Front Cell Infect Microbiol, 2022
Background A relationship between the vaginal microbiota and tenofovir (TFV) concentrations and activity after topical administration has been previously reported.
Thurman AR, Ravel J, Gajer P, Marzinke MA, Ouattara LA, Jacot T, Peet MM, Clark MR, Doncel GF.   +8 more
europepmc   +2 more sources

Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention. [PDF]

AIDS Behav, 2021
Husnik MJ, Brown ER, Dadabhai SS, Gaffoor Z, Jeenarain N, Kiweewa FM, Livant E, Mansoor LE, Mirembe BG, Palanee-Phillips T, Singh D, Siva S, Soto-Torres L, van der Straten A, Baeten JM, M. T. N.-020/ASPIRE Study Team.   +15 more
europepmc   +2 more sources

Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial. [PDF]

J Acquir Immune Defic Syndr, 2022
Background: Persistent use of HIV prevention methods can be a challenge, particularly for some younger women. The long-acting, discreet, woman-centric dapivirine vaginal ring offers promise as a prevention method with less user burden, which could ...
Browne EN, Brown ER, Palanee-Phillips T, Reddy K, Naidoo L, Jeenarain N, Nair G, Husnik MJ, Singh D, Scheckter R, Soto-Torres L, Baeten JM, van der Straten A, MTN-020/ASPIRE Study Team.   +13 more
europepmc   +2 more sources